CASC
SRNE

Coppell Advisory Solutions Corp’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Coppell Advisory Solutions Corp’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$89 – 1202
2022
Q4 		$89 Buy
+100
New +$89 ﹤0.01% 1150